Literature DB >> 18035386

Preferential organ distribution of methylselenol source Se-methylselenocysteine relative to methylseleninic acid.

Kazuo T Suzuki1, Yoshiro Tsuji, Yuki Ohta, Noriyuki Suzuki.   

Abstract

It has been proposed that Se-methylselenocysteine (MeSeCys) and methylseleninic acid (MSA(IV)) are efficiently transformed through the beta-lyase and reduction reactions, respectively, into methylselenol, the assumed biologically active selenometabolite responsive for the anti-carcinogenicity and anti-oxidant actions of selenium. The bioavailability and distribution of the two selenium sources in major organs/tissues were compared under exactly identical conditions. Namely, labeled selenium sources (76)Se-MeSeCys and (77)Se-MSA(IV), at a single oral dose of 10 microg Se/kg body weight each, were administered simultaneously to rats that had been depleted of natural abundance selenium with a single isotope (78)Se. The same dose of (82)Se-selenite was also administered as a reference selenium source. The distributions of the three labeled selenium isotopes were determined 3 h after the administration in 13 organs/tissues/blood. MeSeCys was taken up more efficiently by most organs, especially the pancreas and duodenum, than MSA(IV) and selenite, the latter two sources being taken up similarly to each other except for in the kidney, liver, and spleen, where the three labeled isotopes were detected at comparable concentrations. The labeled selenium in the liver supernatant was speciated by HPLC inductively coupled argon plasma-mass spectrometry (ICP-MS), and it was suggested that MeSeCys was delivered in its intact form to organs, and then transformed into methylselenol. In addition to the known properties of that MeSeCys is chemically more stable than MSA(IV) and is a naturally occurring edible product, and that MeSeCys produces methylselenol much more efficiently than a homologous selenoamino acid selenomethionine, the present study revealed that MeSeCys is more efficiently distributed than MSA(IV) in its intact form, and then produces methylselenol, suggesting that MeSeCys is the best methylselenol source in most organs/tissues.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18035386     DOI: 10.1016/j.taap.2007.10.001

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  9 in total

Review 1.  Chemopreventive mechanisms of α-keto acid metabolites of naturally occurring organoselenium compounds.

Authors:  John T Pinto; Jeong-In Lee; Raghu Sinha; Melanie E MacEwan; Arthur J L Cooper
Journal:  Amino Acids       Date:  2010-04-10       Impact factor: 3.520

2.  Soy content of basal diets determines the effects of supplemental selenium in male mice.

Authors:  Trevor E Quiner; Heather L Nakken; Brock A Mason; Edwin D Lephart; Chad R Hancock; Merrill J Christensen
Journal:  J Nutr       Date:  2011-10-26       Impact factor: 4.798

3.  Quantitative imaging of selenoprotein with multi-isotope imaging mass spectrometry (MIMS).

Authors:  Shiow-Shih Tang; Christelle Guillermier; Mei Wang; Joseph Collin Poczatek; Noriyuki Suzuki; Joseph Loscalzo; Claude Lechene
Journal:  Surf Interface Anal       Date:  2014-11-01       Impact factor: 1.607

4.  Kynurenine aminotransferase III and glutamine transaminase L are identical enzymes that have cysteine S-conjugate β-lyase activity and can transaminate L-selenomethionine.

Authors:  John T Pinto; Boris F Krasnikov; Steven Alcutt; Melanie E Jones; Thambi Dorai; Maria T Villar; Antonio Artigues; Jianyong Li; Arthur J L Cooper
Journal:  J Biol Chem       Date:  2014-09-17       Impact factor: 5.157

5.  Modulation of redox status in human lung cell lines by organoselenocompounds: selenazolidines, selenomethionine, and methylseleninic acid.

Authors:  Robyn L Poerschke; Michael R Franklin; Philip J Moos
Journal:  Toxicol In Vitro       Date:  2008-08-15       Impact factor: 3.500

Review 6.  Cancer chemoprevention research with selenium in the post-SELECT era: Promises and challenges.

Authors:  Junxuan Lü; Jinhui Zhang; Cheng Jiang; Yibin Deng; Nur Özten; Maarten C Bosland
Journal:  Nutr Cancer       Date:  2015-11-23       Impact factor: 2.900

7.  Alpha-keto acid metabolites of naturally occurring organoselenium compounds as inhibitors of histone deacetylase in human prostate cancer cells.

Authors:  Jeong-In Lee; Hui Nian; Arthur J L Cooper; Raghu Sinha; Jenny Dai; William H Bisson; Roderick H Dashwood; John T Pinto
Journal:  Cancer Prev Res (Phila)       Date:  2009-07

Review 8.  Selenium and Sulfur to Produce Allium Functional Crops.

Authors:  Susana González-Morales; Fabián Pérez-Labrada; Ema Laura García-Enciso; Paola Leija-Martínez; Julia Medrano-Macías; Irma Esther Dávila-Rangel; Antonio Juárez-Maldonado; Erika Nohemí Rivas-Martínez; Adalberto Benavides-Mendoza
Journal:  Molecules       Date:  2017-03-30       Impact factor: 4.411

Review 9.  Selenium and selenoproteins: it's role in regulation of inflammation.

Authors:  Sneha Hariharan; Selvakumar Dharmaraj
Journal:  Inflammopharmacology       Date:  2020-03-06       Impact factor: 4.473

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.